Ishare Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.30 M
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 141288.37%
- Profit Growth -33214900.00%
- Ebitda -3578983.09%
- Net Worth 62547.44%
- Total Assets 55658.94%
About Ishare Pharma
Ishare Pharma Private Limited (IPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 June 2013 and has a history of 11 years and seven months. Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Corporate was formerly known as Ishare Solutions Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Rita Govil and Naman Govil serve as directors at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74110UP2013PTC057953
- Company No.
057953
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Ishare Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naman Govil  | Director | 25-Jun-2013 | Current |
| Rita Govil | Director | 06-Aug-2018 | Current |
Financial Performance of Ishare Pharma.
Ishare Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 141288.37% increase. The company also saw a substantial fall in profitability, with a 33214900% decrease in profit. The company's net worth Soared by an impressive increase of 62547.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ishare Pharma?
In 2023, Ishare Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Allons Promoters Private LimitedRita Govil is a mutual person
- Govil And Associates Private Limited
Rita Govil and Naman Govil are mutual person
- Strategicmoves Advisory Private Limited
Rita Govil is a mutual person
- Kay Bee Cold Storage Private Limited
Rita Govil and Naman Govil are mutual person
- Parsuram Cements Private Limited
Rita Govil and Naman Govil are mutual person
- Lenepo Productions Private Limited
Naman Govil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ishare Pharma?
Unlock and access historical data on people associated with Ishare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ishare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ishare Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
